Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03383575 |
|---|---|
| Brief Title: | Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome |
| First Submitted : | December 8, 2017 |
| First Submitted that Met QC Criteria : | December 22, 2017 |
| First Posted : | December 26, 2017 |
| Last Update Submitted that Met QC Criteria : | March 13, 2023 |
| Last Update Posted : | March 14, 2023 |